{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:43:18Z","timestamp":1789180998640,"version":"build-2803163510"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2022JJ30832"],"award-info":[{"award-number":["2022JJ30832"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2022JJ30917"],"award-info":[{"award-number":["2022JJ30917"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81500036"],"award-info":[{"award-number":["81500036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Fund of Hunan Provincial Education Department","award":["21B0005"],"award-info":[{"award-number":["21B0005"]}]},{"name":"Special Fund for Rehabilitation Medicine of the National Clinical Research Center for Geriatric Disorders Clinical Research Fund","award":["2021KFJJ09"],"award-info":[{"award-number":["2021KFJJ09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11010-024-04964-8","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:02:08Z","timestamp":1709395328000},"page":"3293-3303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["New insights of DsbA-L in the pathogenesis of metabolic diseases"],"prefix":"10.1007","volume":"479","author":[{"given":"Siqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfa","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baimei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"issue":"6","key":"4964_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41573-022-00407-5","volume":"21","author":"A Goga","year":"2022","unstructured":"Goga A, Stoffel M (2022) Therapeutic RNA-silencing oligonucleotides in metabolic diseases. Nat Rev Drug Discov 21(6):417\u2013439. https:\/\/doi.org\/10.1038\/s41573-022-00407-5","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"4964_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","volume":"35","author":"NWS Chew","year":"2023","unstructured":"Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH et al (2023) The global burden of metabolic disease: data from 2000 to 2019. Cell Metab 35(3):414-428.e3. https:\/\/doi.org\/10.1016\/j.cmet.2023.02.003","journal-title":"Cell Metab"},{"issue":"5\u20136","key":"4964_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/gad.346312.120","volume":"35","author":"YS Lee","year":"2021","unstructured":"Lee YS, Olefsky J (2021) Chronic tissue inflammation and metabolic disease. Genes Dev 35(5\u20136):307\u2013328. https:\/\/doi.org\/10.1101\/gad.346312.120","journal-title":"Genes Dev"},{"key":"4964_CR4","doi-asserted-by":"publisher","first-page":"101169","DOI":"10.1016\/j.molmet.2021.101169","volume":"47","author":"IL Lemmer","year":"2021","unstructured":"Lemmer IL, Willemsen N, Hilal N, Bartelt A (2021) A guide to understanding endoplasmic reticulum stress in metabolic disorders. Mol Metab 47:101169. https:\/\/doi.org\/10.1016\/j.molmet.2021.101169","journal-title":"Mol Metab"},{"issue":"1","key":"4964_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 19(1):55\u201371. https:\/\/doi.org\/10.1038\/s41579-020-0433-9","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"4964_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/03602532.2011.556122","volume":"43","author":"F Morel","year":"2011","unstructured":"Morel F, Aninat C (2011) The glutathione transferase kappa family. Drug Metab Rev 43(2):281\u201391. https:\/\/doi.org\/10.3109\/03602532.2011.556122","journal-title":"Drug Metab Rev"},{"issue":"10","key":"4964_CR7","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.biochi.2012.01.008","volume":"94","author":"M Liu","year":"2012","unstructured":"Liu M, Liu F (2012) Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication. Biochimie 94(10):2126\u20132130. https:\/\/doi.org\/10.1016\/j.biochi.2012.01.008","journal-title":"Biochimie"},{"key":"4964_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250071","author":"P Cui","year":"2023","unstructured":"Cui P, Chen C, Cui Y, Qiu X, Yue K, Li T et al (2023) DsbA-L deletion attenuates LPS-induced acute kidney injury by modulating macrophage polarization. Eur J Immunol. https:\/\/doi.org\/10.1002\/eji.202250071","journal-title":"Eur J Immunol"},{"issue":"4","key":"4964_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/fjc.0000000000000417","volume":"68","author":"Q Yang","year":"2016","unstructured":"Yang Q, Wang HC, Liu Y, Gao C, Sun L, Tao L (2016) Resveratrol cardioprotection against myocardial ischemia\/reperfusion injury involves upregulation of adiponectin levels and multimerization in type 2 diabetic mice. J Cardiovasc Pharmacol 68(4):304\u2013312. https:\/\/doi.org\/10.1097\/fjc.0000000000000417","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"4964_CR10","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.1038\/s41598-020-62872-5","volume":"10","author":"K Oniki","year":"2020","unstructured":"Oniki K, Nohara H, Nakashima R, Obata Y, Muto N, Sakamoto Y et al (2020) The DsbA-L gene is associated with respiratory function of the elderly via its adiponectin multimeric or antioxidant properties. Sci Rep 10(1):5973. https:\/\/doi.org\/10.1038\/s41598-020-62872-5","journal-title":"Sci Rep"},{"key":"4964_CR11","doi-asserted-by":"publisher","first-page":"1041042","DOI":"10.3389\/fgene.2023.1041042","volume":"14","author":"Y Feng","year":"2023","unstructured":"Feng Y, Zhou YH, Zhao J, Su XL, Chen NX, Zhao YQ et al (2023) Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation. Front Genet 14:1041042. https:\/\/doi.org\/10.3389\/fgene.2023.1041042","journal-title":"Front Genet"},{"issue":"1","key":"4964_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s42003-020-0986-1","volume":"3","author":"J Bai","year":"2020","unstructured":"Bai J, Cervantes C, He S, He J, Plasko GR, Wen J et al (2020) Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutrition-induced obesity in mice. Commun Biol 3(1):257. https:\/\/doi.org\/10.1038\/s42003-020-0986-1","journal-title":"Commun Biol"},{"issue":"46","key":"4964_CR13","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.1073\/pnas.1708744114","volume":"114","author":"J Bai","year":"2017","unstructured":"Bai J, Cervantes C, Liu J, He S, Zhou H, Zhang B et al (2017) DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. Proc Natl Acad Sci USA 114(46):12196\u201312201. https:\/\/doi.org\/10.1073\/pnas.1708744114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"4964_CR14","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1096\/fj.201600985R","volume":"31","author":"H Chen","year":"2017","unstructured":"Chen H, Bai J, Dong F, Fang H, Zhang Y, Meng W et al (2017) Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance. Faseb j 31(6):2314\u20132326. https:\/\/doi.org\/10.1096\/fj.201600985R","journal-title":"Faseb j"},{"issue":"12","key":"4964_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1631\/jzus.B2000432","volume":"21","author":"X Zhou","year":"2020","unstructured":"Zhou X, Li JQ, Wei LJ, He MZ, Jia J, Zhang JY et al (2020) Silencing of DsbA-L gene impairs the PPAR\u03b3 agonist function of improving insulin resistance in a high-glucose cell model. J Zhejiang Univ Sci B 21(12):990\u2013998. https:\/\/doi.org\/10.1631\/jzus.B2000432","journal-title":"J Zhejiang Univ Sci B"},{"issue":"4","key":"4964_CR16","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.3892\/mmr.2017.7284","volume":"16","author":"X Liu","year":"2017","unstructured":"Liu X, Tong W, Zhao X, Zhang H, Tang Y, Deng X (2017) Chinese herb extract improves liver steatosis by promoting the expression of high molecular weight adiponectin in NAFLD rats. Mol Med Rep 16(4):5580\u20135586. https:\/\/doi.org\/10.3892\/mmr.2017.7284","journal-title":"Mol Med Rep"},{"issue":"11","key":"4964_CR17","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.2337\/db12-0169","volume":"61","author":"M Liu","year":"2012","unstructured":"Liu M, Xiang R, Wilk SA, Zhang N, Sloane LB, Azarnoush K et al (2012) Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance. Diabetes 61(11):2776\u20132786. https:\/\/doi.org\/10.2337\/db12-0169","journal-title":"Diabetes"},{"issue":"11","key":"4964_CR18","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.2337\/db10-0412","volume":"59","author":"L Zhou","year":"2010","unstructured":"Zhou L, Liu M, Zhang J, Chen H, Dong LQ, Liu F (2010) DsbA-L alleviates endoplasmic reticulum stress-induced adiponectin downregulation. Diabetes 59(11):2809\u20132816. https:\/\/doi.org\/10.2337\/db10-0412","journal-title":"Diabetes"},{"issue":"1\u20132","key":"4964_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-016-2931-7","volume":"429","author":"E Burlet","year":"2017","unstructured":"Burlet E, Jain SK (2017) Manganese supplementation increases adiponectin and lowers ICAM-1 and creatinine blood levels in Zucker type 2 diabetic rats, and downregulates ICAM-1 by upregulating adiponectin multimerization protein (DsbA-L) in endothelial cells. Mol Cell Biochem 429(1\u20132):1\u201310. https:\/\/doi.org\/10.1007\/s11010-016-2931-7","journal-title":"Mol Cell Biochem"},{"issue":"1\u20132","key":"4964_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11010-016-2664-7","volume":"414","author":"AE Achari","year":"2016","unstructured":"Achari AE, Jain SK (2016) L-Cysteine supplementation increases adiponectin synthesis and secretion, and GLUT4 and glucose utilization by upregulating disulfide bond A-like protein expression mediated by MCP-1 inhibition in 3T3-L1 adipocytes exposed to high glucose. Mol Cell Biochem 414(1\u20132):105\u2013113. https:\/\/doi.org\/10.1007\/s11010-016-2664-7","journal-title":"Mol Cell Biochem"},{"issue":"Pt1","key":"4964_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1042\/bj2780137","volume":"278","author":"JM Harris","year":"1991","unstructured":"Harris JM, Meyer DJ, Coles B, Ketterer B (1991) A novel glutathione transferase (13\u201313) isolated from the matrix of rat liver mitochondria having structural similarity to class theta enzymes. Biochem J 278(Pt1):137\u201341. https:\/\/doi.org\/10.1042\/bj2780137","journal-title":"Biochem J"},{"issue":"47","key":"4964_CR22","doi-asserted-by":"publisher","first-page":"18302","DOI":"10.1073\/pnas.0806341105","volume":"105","author":"M Liu","year":"2008","unstructured":"Liu M, Zhou L, Xu A, Lam KS, Wetzel MD, Xiang R et al (2008) A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci USA 105(47):18302\u201318307. https:\/\/doi.org\/10.1073\/pnas.0806341105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4964_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/002215540405200509","volume":"52","author":"RE Thomson","year":"2004","unstructured":"Thomson RE, Bigley AL, Foster JR, Jowsey IR, Elcombe CR, Orton TC et al (2004) Tissue-specific expression and subcellular distribution of murine glutathione S-transferase class kappa. J Histochem Cytochem 52(5):653\u2013662. https:\/\/doi.org\/10.1177\/002215540405200509","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"4964_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/toxsci\/kfm233","volume":"100","author":"TR Knight","year":"2007","unstructured":"Knight TR, Choudhuri S, Klaassen CD (2007) Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice. Toxicol Sci 100(2):513\u2013524. https:\/\/doi.org\/10.1093\/toxsci\/kfm233","journal-title":"Toxicol Sci"},{"issue":"16","key":"4964_CR25","doi-asserted-by":"publisher","first-page":"16246","DOI":"10.1074\/jbc.M313357200","volume":"279","author":"F Morel","year":"2004","unstructured":"Morel F, Rauch C, Petit E, Piton A, Theret N, Coles B et al (2004) Gene and protein characterization of the human glutathione S-transferase kappa and evidence for a peroxisomal localization. J Biol Chem 279(16):16246\u201316253. https:\/\/doi.org\/10.1074\/jbc.M313357200","journal-title":"J Biol Chem"},{"issue":"16","key":"4964_CR26","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.1074\/jbc.M115.645416","volume":"290","author":"M Liu","year":"2015","unstructured":"Liu M, Chen H, Wei L, Hu D, Dong K, Jia W et al (2015) Endoplasmic reticulum (ER) localization is critical for DsbA-L protein to suppress ER stress and adiponectin down-regulation in adipocytes. J Biol Chem 290(16):10143\u201310148. https:\/\/doi.org\/10.1074\/jbc.M115.645416","journal-title":"J Biol Chem"},{"key":"4964_CR27","doi-asserted-by":"publisher","first-page":"108008","DOI":"10.1016\/j.pharmthera.2021.108008","volume":"232","author":"A Sharma","year":"2022","unstructured":"Sharma A, Mah M, Ritchie RH, De Blasio MJ (2022) The adiponectin signalling pathway\u2014a therapeutic target for the cardiac complications of type 2 diabetes? Pharmacol Ther 232:108008. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108008","journal-title":"Pharmacol Ther"},{"issue":"9","key":"4964_CR28","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1111\/dom.15151","volume":"25","author":"M Gao","year":"2023","unstructured":"Gao M, Cui D, Xie J (2023) The role of adiponectin for immune cell function in metabolic diseases. Diabetes Obes Metab 25(9):2427\u20132438. https:\/\/doi.org\/10.1111\/dom.15151","journal-title":"Diabetes Obes Metab"},{"key":"4964_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.abb.2017.07.016","volume":"630","author":"AE Achari","year":"2017","unstructured":"Achari AE, Jain SK (2017) l-Cysteine supplementation increases insulin sensitivity mediated by upregulation of GSH and adiponectin in high glucose treated 3T3-L1 adipocytes. Arch Biochem Biophys 630:54\u201365. https:\/\/doi.org\/10.1016\/j.abb.2017.07.016","journal-title":"Arch Biochem Biophys"},{"issue":"10382","key":"4964_CR30","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/s0140-6736(22)02403-5","volume":"401","author":"CM Perdomo","year":"2023","unstructured":"Perdomo CM, Cohen RV, Sumithran P, Cl\u00e9ment K, Fr\u00fchbeck G (2023) Contemporary medical, device, and surgical therapies for obesity in adults. Lancet 401(10382):1116\u20131130. https:\/\/doi.org\/10.1016\/s0140-6736(22)02403-5","journal-title":"Lancet"},{"issue":"2","key":"4964_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/biof.1921","volume":"49","author":"C Bertoncini-Silva","year":"2023","unstructured":"Bertoncini-Silva C, Zingg JM, Fassini PG, Suen VMM (2023) Bioactive dietary components-Anti-obesity effects related to energy metabolism and inflammation. BioFactors 49(2):297\u2013321. https:\/\/doi.org\/10.1002\/biof.1921","journal-title":"BioFactors"},{"issue":"1","key":"4964_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s2213-8587(22)00317-5","volume":"11","author":"N Sattar","year":"2023","unstructured":"Sattar N, McMurray JJV, McInnes IB, Aroda VR, Lean MEJ (2023) Treating chronic diseases without tackling excess adiposity promotes multimorbidity. Lancet Diabetes Endocrinol 11(1):58\u201362. https:\/\/doi.org\/10.1016\/s2213-8587(22)00317-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4964_CR33","doi-asserted-by":"publisher","first-page":"706978","DOI":"10.3389\/fendo.2021.706978","volume":"12","author":"X Lin","year":"2021","unstructured":"Lin X, Li H (2021) Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol (Lausanne) 12:706978. https:\/\/doi.org\/10.3389\/fendo.2021.706978","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"4964_CR34","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","volume":"320","author":"T Kawai","year":"2021","unstructured":"Kawai T, Autieri MV, Scalia R (2021) Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 320(3):C375-c391. https:\/\/doi.org\/10.1152\/ajpcell.00379.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"4964_CR35","doi-asserted-by":"publisher","first-page":"115012","DOI":"10.1016\/j.bcp.2022.115012","volume":"199","author":"RH Lustig","year":"2022","unstructured":"Lustig RH, Collier D, Kassotis C, Roepke TA, Kim MJ, Blanc E et al (2022) Obesity I: overview and molecular and biochemical mechanisms. Biochem Pharmacol 199:115012. https:\/\/doi.org\/10.1016\/j.bcp.2022.115012","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"4964_CR36","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41423-019-0296-z","volume":"18","author":"X Unamuno","year":"2021","unstructured":"Unamuno X, G\u00f3mez-Ambrosi J, Ram\u00edrez B, Rodr\u00edguez A, Becerril S, Valent\u00ed V et al (2021) NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling. Cell Mol Immunol 18(4):1045\u20131057. https:\/\/doi.org\/10.1038\/s41423-019-0296-z","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"4964_CR37","doi-asserted-by":"publisher","first-page":"165838","DOI":"10.1016\/j.bbadis.2020.165838","volume":"1866","author":"P Prasun","year":"2020","unstructured":"Prasun P (2020) Mitochondrial dysfunction in metabolic syndrome. Biochim Biophys Acta Mol Basis Dis 1866(10):165838. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165838","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"4964_CR38","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/15548627.2021.1985257","volume":"18","author":"P Ahuja","year":"2022","unstructured":"Ahuja P, Ng CF, Pang BPS, Chan WS, Tse MCL, Bi X et al (2022) Muscle-generated BDNF (brain derived neurotrophic factor) maintains mitochondrial quality control in female mice. Autophagy 18(6):1367\u20131384. https:\/\/doi.org\/10.1080\/15548627.2021.1985257","journal-title":"Autophagy"},{"issue":"1","key":"4964_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/med.21921","volume":"43","author":"A Ajoolabady","year":"2023","unstructured":"Ajoolabady A, Lebeaupin C, Wu NN, Kaufman RJ, Ren J (2023) ER stress and inflammation crosstalk in obesity. Med Res Rev 43(1):5\u201330. https:\/\/doi.org\/10.1002\/med.21921","journal-title":"Med Res Rev"},{"key":"4964_CR40","doi-asserted-by":"publisher","first-page":"106741","DOI":"10.1016\/j.intimp.2020.106741","volume":"86","author":"YB Han","year":"2020","unstructured":"Han YB, Tian M, Wang XX, Fan DH, Li WZ, Wu F et al (2020) Berberine ameliorates obesity-induced chronic inflammation through suppression of ER stress and promotion of macrophage M2 polarization at least partly via downregulating lncRNA Gomafu. Int Immunopharmacol 86:106741. https:\/\/doi.org\/10.1016\/j.intimp.2020.106741","journal-title":"Int Immunopharmacol"},{"key":"4964_CR41","doi-asserted-by":"publisher","first-page":"659751","DOI":"10.3389\/fphys.2021.659751","volume":"12","author":"M Yang","year":"2021","unstructured":"Yang M, Luo S, Jiang N, Wang X, Han Y, Zhao H et al (2021) DsbA-L Ameliorates renal injury through the AMPK\/NLRP3 inflammasome signaling pathway in diabetic nephropathy. Front Physiol 12:659751. https:\/\/doi.org\/10.3389\/fphys.2021.659751","journal-title":"Front Physiol"},{"key":"4964_CR42","doi-asserted-by":"publisher","first-page":"1902025","DOI":"10.1155\/2016\/1902025","volume":"2016","author":"S Bai","year":"2016","unstructured":"Bai S, Cheng L, Yang Y, Fan C, Zhao D, Qin Z et al (2016) C1q\/TNF-related protein 9 protects diabetic rat heart against ischemia reperfusion injury: role of endoplasmic reticulum stress. Oxid Med Cell Longev 2016:1902025. https:\/\/doi.org\/10.1155\/2016\/1902025","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"4964_CR43","doi-asserted-by":"publisher","first-page":"e71285","DOI":"10.1371\/journal.pone.0071285","volume":"8","author":"D Wanders","year":"2013","unstructured":"Wanders D, Graff EC, White BD, Judd RL (2013) Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice. PloS one 8(8):e71285. https:\/\/doi.org\/10.1371\/journal.pone.0071285","journal-title":"PloS one"},{"issue":"3","key":"4964_CR44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1507\/endocrj.k08e-322","volume":"56","author":"F Gao","year":"2009","unstructured":"Gao F, Fang Q, Zhang R, Lu J, Lu H, Wang C et al (2009) Polymorphism of DsbA-L gene associates with insulin secretion and body fat distribution in Chinese population. Endocr J 56(3):487\u2013494. https:\/\/doi.org\/10.1507\/endocrj.k08e-322","journal-title":"Endocr J"},{"issue":"11","key":"4964_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1248\/yakushi.22-00128","volume":"142","author":"K Oniki","year":"2022","unstructured":"Oniki K (2022) Multifaceted clinical research on obesity-related disease prevention focusing on the DsbA-L gene. Yakugaku Zasshi 142(11):1177\u20131183. https:\/\/doi.org\/10.1248\/yakushi.22-00128","journal-title":"Yakugaku Zasshi"},{"issue":"1","key":"4964_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1248\/yakushi.18-00163-3","volume":"139","author":"K Oniki","year":"2019","unstructured":"Oniki K, Saruwatari J (2019) a multifaceted approach regarding the association of the DsbA-L gene with the risk of obesity-related diseases based on clinical pharmacogenetics. Yakugaku Zasshi 139(1):53\u201360. https:\/\/doi.org\/10.1248\/yakushi.18-00163-3","journal-title":"Yakugaku Zasshi"},{"issue":"8","key":"4964_CR47","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4161\/auto.6.8.13478","volume":"6","author":"L Zhou","year":"2010","unstructured":"Zhou L, Liu F (2010) Autophagy: roles in obesity-induced ER stress and adiponectin downregulation in adipocytes. Autophagy 6(8):1196\u20131197. https:\/\/doi.org\/10.4161\/auto.6.8.13478","journal-title":"Autophagy"},{"issue":"3","key":"4964_CR48","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","volume":"55","author":"J Kim","year":"2023","unstructured":"Kim J, Kim HS, Chung JH (2023) Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp Mol Med 55(3):510\u2013519. https:\/\/doi.org\/10.1038\/s12276-023-00965-7","journal-title":"Exp Mol Med"},{"issue":"9","key":"4964_CR49","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21(9):548\u2013569. https:\/\/doi.org\/10.1038\/s41577-021-00524-z","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"4964_CR50","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","volume":"33","author":"C Chen","year":"2023","unstructured":"Chen C, Xu P (2023) Cellular functions of cGAS-STING signaling. Trends Cell Biol 33(8):630\u2013648. https:\/\/doi.org\/10.1016\/j.tcb.2022.11.001","journal-title":"Trends Cell Biol"},{"issue":"9","key":"4964_CR51","doi-asserted-by":"publisher","first-page":"e23127","DOI":"10.1096\/fj.202300342RRR","volume":"37","author":"Z Feng","year":"2023","unstructured":"Feng Z, Liao X, Peng J, Quan J, Zhang H, Huang Z et al (2023) PCSK9 causes inflammation and cGAS\/STING pathway activation in diabetic nephropathy. Faseb j 37(9):e23127. https:\/\/doi.org\/10.1096\/fj.202300342RRR","journal-title":"Faseb j"},{"issue":"1","key":"4964_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","volume":"12","author":"PK Oduro","year":"2022","unstructured":"Oduro PK, Zheng X, Wei J, Yang Y, Wang Y, Zhang H et al (2022) The cGAS-STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy. Acta Pharm Sin B 12(1):50\u201375. https:\/\/doi.org\/10.1016\/j.apsb.2021.05.011","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"4964_CR53","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10565-021-09692-z","volume":"39","author":"XM Ma","year":"2023","unstructured":"Ma XM, Geng K, Law BY, Wang P, Pu YL, Chen Q et al (2023) Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes. Cell Biol Toxicol 39(1):277\u2013299. https:\/\/doi.org\/10.1007\/s10565-021-09692-z","journal-title":"Cell Biol Toxicol"},{"issue":"5","key":"4964_CR54","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/atvbaha.117.309017","volume":"37","author":"Y Mao","year":"2017","unstructured":"Mao Y, Luo W, Zhang L, Wu W, Yuan L, Xu H et al (2017) STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity. Arterioscler Thromb Vasc Biol 37(5):920\u2013929. https:\/\/doi.org\/10.1161\/atvbaha.117.309017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4964_CR55","doi-asserted-by":"publisher","first-page":"121978","DOI":"10.1016\/j.lfs.2023.121978","volume":"330","author":"M Jia","year":"2023","unstructured":"Jia M, Xu T, Xu YJ, Liu Y (2023) Dietary fatty acids activate or deactivate brown and beige fat. Life Sci 330:121978. https:\/\/doi.org\/10.1016\/j.lfs.2023.121978","journal-title":"Life Sci"},{"issue":"Suppl 1","key":"4964_CR56","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al (2023) Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 46(Suppl 1):S19\u2013S40. https:\/\/doi.org\/10.2337\/dc23-S002","journal-title":"Diabetes Care"},{"issue":"10384","key":"4964_CR57","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/s0140-6736(23)00001-6","volume":"401","author":"EW Gregg","year":"2023","unstructured":"Gregg EW, Buckley J, Ali MK, Davies J, Flood D, Mehta R et al (2023) Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact. Lancet 401(10384):1302\u20131312. https:\/\/doi.org\/10.1016\/s0140-6736(23)00001-6","journal-title":"Lancet"},{"key":"4964_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086978","author":"H Guo","year":"2023","unstructured":"Guo H, Wu H, Li Z (2023) The pathogenesis of diabetes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24086978","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4964_CR59","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11684-019-0729-1","volume":"14","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li T, Wu X, Nice EC, Huang C, Zhang Y (2020) Oxidative stress and diabetes: antioxidative strategies. Front Med 14(5):583\u2013600. https:\/\/doi.org\/10.1007\/s11684-019-0729-1","journal-title":"Front Med"},{"issue":"1","key":"4964_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12933-023-01965-7","volume":"22","author":"Y An","year":"2023","unstructured":"An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y et al (2023) The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol 22(1):237. https:\/\/doi.org\/10.1186\/s12933-023-01965-7","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4964_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40618-018-0873-5","volume":"42","author":"A Samadi","year":"2019","unstructured":"Samadi A, Gurlek A, Sendur SN, Karahan S, Akbiyik F, Lay I (2019) Oxysterol species: reliable markers of oxidative stress in diabetes mellitus. J Endocrinol Invest 42(1):7\u201317. https:\/\/doi.org\/10.1007\/s40618-018-0873-5","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"4964_CR62","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc19-0292","volume":"42","author":"Y Xuan","year":"2019","unstructured":"Xuan Y, G\u00e0o X, Anusruti A, Holleczek B, Jansen E, Muhlack DC et al (2019) Association of serum markers of oxidative stress with incident major cardiovascular events, cancer incidence, and all-cause mortality in type 2 diabetes patients: pooled results from two cohort studies. Diabetes Care 42(8):1436\u20131445. https:\/\/doi.org\/10.2337\/dc19-0292","journal-title":"Diabetes Care"},{"key":"4964_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415743","author":"M Wronka","year":"2022","unstructured":"Wronka M, Krzemi\u0144ska J, M\u0142ynarska E, Rysz J, Franczyk B (2022) The influence of lifestyle and treatment on oxidative stress and inflammation in diabetes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232415743","journal-title":"Int J Mol Sci"},{"key":"4964_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cytogfr.2022.04.002","volume":"66","author":"D Gao","year":"2022","unstructured":"Gao D, Jiao J, Wang Z, Huang X, Ni X, Fang S et al (2022) The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment. Cytokine Growth Factor Rev 66:15\u201325. https:\/\/doi.org\/10.1016\/j.cytogfr.2022.04.002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"7","key":"4964_CR65","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1042\/cs20200005","volume":"134","author":"P Gao","year":"2020","unstructured":"Gao P, Yang M, Chen X, Xiong S, Liu J, Sun L (2020) DsbA-L deficiency exacerbates mitochondrial dysfunction of tubular cells in diabetic kidney disease. Clin Sci (Lond) 134(7):677\u2013694. https:\/\/doi.org\/10.1042\/cs20200005","journal-title":"Clin Sci (Lond)"},{"key":"4964_CR66","doi-asserted-by":"publisher","first-page":"102855","DOI":"10.1016\/j.redox.2023.102855","volume":"66","author":"Y Liu","year":"2023","unstructured":"Liu Y, Chen W, Li C, Li L, Yang M, Jiang N et al (2023) DsbA-L interacting with catalase in peroxisome improves tubular oxidative damage in diabetic nephropathy. Redox Biol 66:102855. https:\/\/doi.org\/10.1016\/j.redox.2023.102855","journal-title":"Redox Biol"},{"issue":"9","key":"4964_CR67","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1055\/s-0042-109262","volume":"124","author":"K Lian","year":"2016","unstructured":"Lian K, Guo X, Huang Q, Tan Z, Xia C, Wang R et al (2016) Reduction levels and the effects of high-molecular-weight adiponectin via AMPK\/eNOS in Chinese type 2 diabetes. Exp Clin Endocrinol Diabetes 124(9):541\u2013547. https:\/\/doi.org\/10.1055\/s-0042-109262","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"4964_CR68","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/dme.14132","volume":"37","author":"X Deng","year":"2020","unstructured":"Deng X, Yang G, Zheng X, Yang Y, Qin H, Liu ZX et al (2020) Plasma mtDNA copy numbers are associated with GSTK1 expression and inflammation in type 2 diabetes. Diabet Med 37(11):1874\u20131878. https:\/\/doi.org\/10.1111\/dme.14132","journal-title":"Diabet Med"},{"key":"4964_CR69","doi-asserted-by":"publisher","first-page":"128350","DOI":"10.1016\/j.chemosphere.2020.128350","volume":"262","author":"JG Paithankar","year":"2021","unstructured":"Paithankar JG, Saini S, Dwivedi S, Sharma A, Chowdhuri DK (2021) Heavy metal associated health hazards: an interplay of oxidative stress and signal transduction. Chemosphere 262:128350. https:\/\/doi.org\/10.1016\/j.chemosphere.2020.128350","journal-title":"Chemosphere"},{"issue":"2","key":"4964_CR70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","volume":"6","author":"G Solinas","year":"2017","unstructured":"Solinas G, Becattini B (2017) JNK at the crossroad of obesity, insulin resistance, and cell stress response. Mol Metab 6(2):174\u2013184. https:\/\/doi.org\/10.1016\/j.molmet.2016.12.001","journal-title":"Mol Metab"},{"key":"4964_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030706","author":"JHM Yung","year":"2020","unstructured":"Yung JHM, Giacca A (2020) Role of c-Jun N-terminal Kinase (JNK) in obesity and type 2 diabetes. Cells. https:\/\/doi.org\/10.3390\/cells9030706","journal-title":"Cells"},{"issue":"4","key":"4964_CR72","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00018-022-04230-4","volume":"79","author":"BR Gehi","year":"2022","unstructured":"Gehi BR, Gadhave K, Uversky VN, Giri R (2022) Intrinsic disorder in proteins associated with oxidative stress-induced JNK signaling. Cell Mol Life Sci 79(4):202. https:\/\/doi.org\/10.1007\/s00018-022-04230-4","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4964_CR73","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Hu K, Cai X, Yang B, He Q, Wang J et al (2022) Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B 12(1):18\u201332. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.023","journal-title":"Acta Pharm Sin B"},{"key":"4964_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","volume":"80","author":"D Tewari","year":"2022","unstructured":"Tewari D, Patni P, Bishayee A, Sah AN, Bishayee A (2022) Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol 80:1\u201317. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.008","journal-title":"Semin Cancer Biol"},{"key":"4964_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315330","author":"M Acosta-Martinez","year":"2022","unstructured":"Acosta-Martinez M, Cabail MZ (2022) The PI3K\/Akt Pathway in Meta-Inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232315330","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4964_CR76","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2337\/dbi18-0052","volume":"68","author":"J Bai","year":"2019","unstructured":"Bai J, Liu F (2019) The cGAS-cGAMP-STING pathway: a molecular link between immunity and metabolism. Diabetes 68(6):1099\u20131108. https:\/\/doi.org\/10.2337\/dbi18-0052","journal-title":"Diabetes"},{"issue":"10","key":"4964_CR77","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/jmcb\/mjab066","volume":"13","author":"J Bai","year":"2021","unstructured":"Bai J, Liu F (2021) cGAS-STING signaling and function in metabolism and kidney diseases. J Mol Cell Biol 13(10):728\u2013738. https:\/\/doi.org\/10.1093\/jmcb\/mjab066","journal-title":"J Mol Cell Biol"},{"issue":"18","key":"4964_CR78","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/cs20220572","volume":"136","author":"OO Badmus","year":"2022","unstructured":"Badmus OO, Hillhouse SA, Anderson CD, Hinds TD, Stec DE (2022) Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways. Clin Sci (Lond) 136(18):1347\u20131366. https:\/\/doi.org\/10.1042\/cs20220572","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"4964_CR79","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS (2023) Global burden of liver disease: 2023 update. J Hepatol 79(2):516\u2013537. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017","journal-title":"J Hepatol"},{"issue":"4","key":"4964_CR80","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77(4):1335\u20131347. https:\/\/doi.org\/10.1097\/hep.0000000000000004","journal-title":"Hepatology"},{"key":"4964_CR81","doi-asserted-by":"publisher","DOI":"10.1530\/joe-22-0194","author":"L Wiering","year":"2023","unstructured":"Wiering L, Tacke F (2023) Treating inflammation to combat non-alcoholic fatty liver disease. J Endocrinol. https:\/\/doi.org\/10.1530\/joe-22-0194","journal-title":"J Endocrinol"},{"issue":"1","key":"4964_CR82","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.31658","volume":"74","author":"X Hou","year":"2021","unstructured":"Hou X, Yin S, Ren R, Liu S, Yong L, Liu Y et al (2021) Myeloid-cell-specific IL-6 signaling promotes MicroRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis. Hepatology 74(1):116\u2013132. https:\/\/doi.org\/10.1002\/hep.31658","journal-title":"Hepatology"},{"issue":"11","key":"4964_CR83","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1111\/jgh.15631","volume":"36","author":"V Potoupni","year":"2021","unstructured":"Potoupni V, Georgiadou M, Chatzigriva E, Polychronidou G, Markou E, Zapantis Gakis C et al (2021) Circulating tumor necrosis factor-\u03b1 levels in non-alcoholic fatty liver disease: a systematic review and a meta-analysis. J Gastroenterol Hepatol 36(11):3002\u20133014. https:\/\/doi.org\/10.1111\/jgh.15631","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"4964_CR84","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/bph.14938","volume":"177","author":"Q Wang","year":"2020","unstructured":"Wang Q, Ou Y, Hu G, Wen C, Yue S, Chen C et al (2020) Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice. Br J Pharmacol 177(8):1806\u20131821. https:\/\/doi.org\/10.1111\/bph.14938","journal-title":"Br J Pharmacol"},{"key":"4964_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137280","author":"R Ramanathan","year":"2022","unstructured":"Ramanathan R, Ali AH, Ibdah JA (2022) Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23137280","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4964_CR86","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12967-023-04367-1","volume":"21","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Wang S, Wu J, Wang Y (2023) Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. J Transl Med 21(1):510. https:\/\/doi.org\/10.1186\/s12967-023-04367-1","journal-title":"J Transl Med"},{"key":"4964_CR87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mito.2020.12.010","volume":"57","author":"S Ajaz","year":"2021","unstructured":"Ajaz S, McPhail MJ, Gnudi L, Trovato FM, Mujib S, Napoli S et al (2021) Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD). Mitochondrion 57:119\u2013130. https:\/\/doi.org\/10.1016\/j.mito.2020.12.010","journal-title":"Mitochondrion"},{"issue":"16","key":"4964_CR88","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1111\/bph.15099","volume":"177","author":"L Wu","year":"2020","unstructured":"Wu L, Mo W, Feng J, Li J, Yu Q, Li S et al (2020) Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21\/PGC-1\u03b1 pathway. Br J Pharmacol 177(16):3760\u20133777. https:\/\/doi.org\/10.1111\/bph.15099","journal-title":"Br J Pharmacol"},{"key":"4964_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/md19030148","author":"PH Shih","year":"2021","unstructured":"Shih PH, Shiue SJ, Chen CN, Cheng SW, Lin HY, Wu LW et al (2021) Fucoidan and fucoxanthin attenuate hepatic steatosis and inflammation of NAFLD through modulation of leptin\/adiponectin axis. Mar Drugs. https:\/\/doi.org\/10.3390\/md19030148","journal-title":"Mar Drugs"},{"issue":"4","key":"4964_CR90","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00125-021-05649-3","volume":"65","author":"BL Moyce Gruber","year":"2022","unstructured":"Moyce Gruber BL, Cole LK, Xiang B, Fonseca MA, Klein J, Hatch GM et al (2022) Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice. Diabetologia 65(4):733\u2013747. https:\/\/doi.org\/10.1007\/s00125-021-05649-3","journal-title":"Diabetologia"},{"issue":"1","key":"4964_CR91","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jcsm.13148","volume":"14","author":"CM Selvais","year":"2023","unstructured":"Selvais CM, Davis-L\u00f3pez de Carrizosa MA, Nachit M, Versele R, Dubuisson N, Noel L et al (2023) AdipoRon enhances healthspan in middle-aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers. J Cachexia Sarcopenia Muscle 14(1):464\u2013478. https:\/\/doi.org\/10.1002\/jcsm.13148","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"47","key":"4964_CR92","doi-asserted-by":"publisher","first-page":"18077","DOI":"10.1073\/pnas.0810027105","volume":"105","author":"ZV Wang","year":"2008","unstructured":"Wang ZV, Scherer PE (2008) DsbA-L is a versatile player in adiponectin secretion. Proc Natl Acad Sci USA 105(47):18077\u201318078. https:\/\/doi.org\/10.1073\/pnas.0810027105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"4964_CR93","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/psp4.12292","volume":"7","author":"K Oniki","year":"2018","unstructured":"Oniki K, Watanabe T, Kudo M, Izuka T, Ono T, Matsuda K et al (2018) Modeling of the weight status and risk of nonalcoholic fatty liver disease in elderly individuals: the potential impact of the disulfide bond-forming oxidoreductase a-like protein (DsbA-L) polymorphism on the weight status. CPT Pharmacometrics Syst Pharmacol 7(6):384\u2013393. https:\/\/doi.org\/10.1002\/psp4.12292","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"4964_CR94","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","volume":"76","author":"E Scorletti","year":"2022","unstructured":"Scorletti E, Carr RM (2022) A new perspective on NAFLD: Focusing on lipid droplets. J Hepatol 76(4):934\u2013945. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.009","journal-title":"J Hepatol"},{"issue":"3","key":"4964_CR95","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","volume":"26","author":"L An","year":"2022","unstructured":"An L, Wirth U, Koch D, Schirren M, Drefs M, Koliogiannis D et al (2022) The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases. J Gastrointest Surg 26(3):671\u2013683. https:\/\/doi.org\/10.1007\/s11605-021-05188-7","journal-title":"J Gastrointest Surg"},{"issue":"12","key":"4964_CR96","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","volume":"43","author":"A Orea-Soufi","year":"2022","unstructured":"Orea-Soufi A, Paik J, Bragan\u00e7a J, Donlon TA, Willcox BJ, Link W (2022) FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol Sci 43(12):1070\u20131084. https:\/\/doi.org\/10.1016\/j.tips.2022.09.010","journal-title":"Trends Pharmacol Sci"},{"key":"4964_CR97","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molmet.2018.09.011","volume":"20","author":"LS Lundell","year":"2019","unstructured":"Lundell LS, Massart J, Alt\u0131nta\u015f A, Krook A, Zierath JR (2019) Regulation of glucose uptake and inflammation markers by FOXO1 and FOXO3 in skeletal muscle. Mol Metab 20:79\u201388. https:\/\/doi.org\/10.1016\/j.molmet.2018.09.011","journal-title":"Mol Metab"},{"issue":"2","key":"4964_CR98","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bbrc.2008.11.043","volume":"378","author":"Y Ito","year":"2009","unstructured":"Ito Y, Daitoku H, Fukamizu A (2009) Foxo1 increases pro-inflammatory gene expression by inducing C\/EBPbeta in TNF-alpha-treated adipocytes. Biochem Biophys Res Commun 378(2):290\u2013295. https:\/\/doi.org\/10.1016\/j.bbrc.2008.11.043","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4964_CR99","doi-asserted-by":"publisher","first-page":"C239","DOI":"10.1152\/ajpcell.00194.2016","volume":"313","author":"S Sundaresan","year":"2017","unstructured":"Sundaresan S, Puthanveetil P (2017) Is FoxO1 the culprit, partner in crime, or a protector in systemic inflammation? Am J Physiol Cell Physiol 313(2):C239-c241. https:\/\/doi.org\/10.1152\/ajpcell.00194.2016","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"4964_CR100","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1002\/jcb.28260","volume":"120","author":"L Chen","year":"2019","unstructured":"Chen L, Gao B, Zhang Y, Lu H, Li X, Pan L et al (2019) PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway. J Cell Biochem 120(6):9799\u20139809. https:\/\/doi.org\/10.1002\/jcb.28260","journal-title":"J Cell Biochem"},{"key":"4964_CR101","doi-asserted-by":"publisher","DOI":"10.1172\/jci154333","author":"S Lee","year":"2022","unstructured":"Lee S, Usman TO, Yamauchi J, Chhetri G, Wang X, Coudriet GM et al (2022) Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis. J Clin Invest. https:\/\/doi.org\/10.1172\/jci154333","journal-title":"J Clin Invest"},{"issue":"1","key":"4964_CR102","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1074\/jbc.M110.188144","volume":"286","author":"A Wang","year":"2011","unstructured":"Wang A, Liu M, Liu X, Dong LQ, Glickman RD, Slaga TJ et al (2011) Up-regulation of adiponectin by resveratrol: the essential roles of the Akt\/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L. J Biol Chem 286(1):60\u201366. https:\/\/doi.org\/10.1074\/jbc.M110.188144","journal-title":"J Biol Chem"},{"key":"4964_CR103","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2022.5141","author":"C Li","year":"2022","unstructured":"Li C, Ma D, Chen Y, Liu W, Jin F, Bo L (2022) Selective inhibition of JNK located on mitochondria protects against mitochondrial dysfunction and cell death caused by endoplasmic reticulum stress in mice with LPS-induced ALI\/ARDS. Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2022.5141","journal-title":"Int J Mol Med"},{"issue":"12","key":"4964_CR104","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/jcb.30146","volume":"122","author":"KH Lin","year":"2021","unstructured":"Lin KH, Ng SC, Paul CR, Chen HC, Zeng RY, Liu JS et al (2021) MicroRNA-210 repression facilitates advanced glycation end-product (AGE)-induced cardiac mitochondrial dysfunction and apoptosis via JNK activation. J Cell Biochem 122(12):1873\u20131885. https:\/\/doi.org\/10.1002\/jcb.30146","journal-title":"J Cell Biochem"},{"issue":"8","key":"4964_CR105","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/abbs\/gmaa074","volume":"52","author":"F Fadel","year":"2020","unstructured":"Fadel F, Al-Kandari N, Khashab F, Al-Saleh F, Al-Maghrebi M (2020) JNK inhibition alleviates oxidative DNA damage, germ cell apoptosis, and mitochondrial dysfunction in testicular ischemia reperfusion injury. Acta Biochim Biophys Sin (Shanghai) 52(8):891\u2013900. https:\/\/doi.org\/10.1093\/abbs\/gmaa074","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"4964_CR106","doi-asserted-by":"publisher","first-page":"863756","DOI":"10.3389\/fphar.2022.863756","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Xu J, Huang P, Yang L, Liu Y, Li Y et al (2022) Scoparone improves nonalcoholic steatohepatitis through alleviating JNK\/Sab signaling pathway-mediated mitochondrial dysfunction. Front Pharmacol 13:863756. https:\/\/doi.org\/10.3389\/fphar.2022.863756","journal-title":"Front Pharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-04964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-04964-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-04964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T07:36:54Z","timestamp":1729841814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-04964-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":106,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4964"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-04964-8","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}